What it takes to defend deceptive placebo use

Area of Science:

• Bioethics
• Medical Ethics
• Philosophy of Medicine

Background:

• Deceptive placebo use in clinical practice presents significant ethical challenges.
• A key ethical objection is that it violates patient autonomy by undermining informed consent.
• This objection is often conflated with other ethical concerns regarding placebo interventions.

Purpose of the Study:

• To analyze how bioethicists have addressed the ethical objection that deceptive placebo use violates patient autonomy.
• To evaluate the adequacy of existing responses to this specific ethical challenge.
• To propose a framework for defending deceptive placebo use as compatible with informed consent.

Main Methods:

• Literature review and critical analysis of bioethical arguments concerning placebo use.
• Examination of responses by prominent bioethicists to the autonomy-based objection.
• Philosophical argumentation drawing on principles of informed consent and patient autonomy.

Main Results:

• Existing bioethical literature often fails to clearly distinguish the autonomy objection from other ethical issues.
• Some responses to the autonomy objection are inadequate or evasive.
• A defense of deceptive placebo use requires a nuanced understanding of informed consent.

Conclusions:

• Defenders of deceptive placebo use must directly confront the autonomy objection.
• Following Onora O'Neill's work, it is argued that deceptive placebo use can be compatible with informed consent.
• Reconciling deceptive placebo use with informed consent requires careful ethical reasoning.